Allogene Therapeutics has a total of 547 patents globally, out of which 101 have been granted. Of these 547 patents, more than 88% patents are active. United States of America is where Allogene Therapeutics has filed the maximum number of patents, followed by Hong Kong and Australia. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Allogene Therapeutics.
Allogene Therapeutics founded in 2017 and based in South San Francisco, is a clinical-stage biotechnology company developing allogeneic CAR T (AlloCAR T™) therapies. The company focuses on advancing innovative cell therapies to treat cancer and autoimmune diseases, leveraging its expertise in oncology, immunotherapy, and biotechnology.
Do read about some of the most popular patents of Allogene Therapeutics which have been covered by us in this article and also you can find Allogene Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Allogene Therapeutics patent portfolio.
How many patents does Allogene Therapeutics have?
Allogene Therapeutics has a total of 547 patents globally. These patents belong to 42 unique patent families. Out of 547 patents, 481 patents are active.
How Many Patents did Allogene Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Allogene Therapeutics Applications Filed | Allogene Therapeutics Patents Granted |
| 2025 | 9 | 29 |
| 2024 | 28 | 38 |
| 2023 | 71 | 14 |
| 2022 | 86 | 6 |
| 2021 | 81 | 10 |
| 2020 | 161 | 4 |
| 2019 | 35 | – |
| 2018 | 48 | – |
| 2017 | 2 | – |
| 2016 | 15 | – |
How many Allogene Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Allogene Therapeutics File in Different Countries?
Countries in which Allogene Therapeutics Filed Patents
| Country | Patents |
| United States of America | 50 |
| Hong Kong (S.A.R.) | 39 |
| Australia | 37 |
| China | 37 |
| Europe (EPO) | 36 |
| Canada | 33 |
| Japan | 32 |
| Mexico | 26 |
| Korea (South) | 25 |
| Israel | 25 |
| India | 23 |
| Brazil | 21 |
| Singapore | 18 |
| Russia | 17 |
| Taiwan | 11 |
| Argentina | 8 |
| Malaysia | 8 |
| South Africa | 7 |
| Indonesia | 7 |
| Philippines | 6 |
| Colombia | 6 |
| Peru | 6 |
| Saudi Arabia | 5 |
| New Zealand | 5 |
| Germany | 4 |
| Italy | 4 |
| Spain | 3 |
| Denmark | 3 |
| Macao | 3 |
| Finland | 2 |
| Norway | 2 |
| Austria | 1 |
Where are Research Centres of Allogene Therapeutics Patents Located?
10 Best Allogene Therapeutics Patents
WO2019169290A1 is the most popular patent in the Allogene Therapeutics portfolio. It has received 33 citations so far from companies like Quell Therapeutics, Exuma Biotech & Simurx.
Below is the list of 10 most cited patents of Allogene Therapeutics:
| Publication Number | Citation Count |
| WO2019169290A1 | 44 |
| US20180002435A1 | 42 |
| WO2020180664A1 | 23 |
| WO2018193394A1 | 23 |
| WO2020180694A1 | 22 |
| WO2021146604A1 | 19 |
| WO2020180591A1 | 18 |
| CN107074973A | 13 |
| WO2020112796A1 | 11 |
| WO2021173630A1 | 10 |
What Percentage of Allogene Therapeutics US Patent Applications were Granted?
Allogene Therapeutics (Excluding its subsidiaries) has filed 45 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 10 have been granted leading to a grant rate of 66.67%.
Below are the key stats of Allogene Therapeutics patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Allogene Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Allogene Therapeutics (Inhouse IP Dept.) | 36 | 83.33% |
| Mintz | 5 | 0.00% |
| Casimir Jones Sc | 2 | 0.00% |
| Cooley Llp | 1 | 0% |
| Sterne Kessler Goldstein & Fox Pllc | 1 | 0% |
What are Allogene Therapeutics key innovation segments?
What Technologies are Covered by Allogene Therapeutics?
The chart below distributes patents filed by Allogene Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Allogene Therapeutics thinks it’s important to protect particular technological inventions.
R&D Focus: How has Allogene Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Allogene Therapeutics?
